BIO-key International, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.9M | $6.9M | $7.8M | $7.0M | $5.1M | $2.8M | $2.3M | $4.0M |
| Cost of Revenue | $1.4M | $1.3M | $6.3M | $2.4M | $1.7M | $794.8K | $2.5M | $4.2M |
| Gross Profit | $4.6M | $5.6M | $1.4M | $4.6M | $3.4M | $2.0M | $-193.7K | $-119.6K |
| Gross Margin | 76.9% | 81.4% | 18.5% | 65.2% | 67.3% | 72.0% | -8.5% | -3.0% |
| Operating Expenses | ||||||||
| Research & Development | $2.6M | $2.5M | $2.4M | $3.3M | $2.4M | $1.4M | $1.3M | $1.4M |
| SG&A Expense | $6.3M | $7.1M | $7.9M | $9.4M | $6.0M | $5.8M | $5.0M | $5.3M |
| Operating Income | $-6.8M | $-4.0M | $-8.8M | $-9.9M | $-4.9M | $-5.2M | $-1.1M | $80 |
| Operating Margin | -115.0% | -57.9% | -113.8% | -141.4% | -96.6% | -183.4% | -47.1% | 0.0% |
| Interest Expense | — | — | $218.3K | $10.5K | $18.0K | $4.3M | $1.1M | — |
| Pretax Income | $-7.1M | $-4.3M | $-8.7M | $-11.9M | $0 | — | — | — |
| Income Tax Expense | $16.5K | $-23.0K | $-134.0K | $-20.4K | $0 | $0 | $0 | $0 |
| Net Income | $-7.2M | $-4.3M | $-8.5M | $-11.9M | $-5.1M | $-9.7M | $-14.6M | $-6.9M |
| Net Margin | -120.6% | -62.1% | -109.9% | -169.7% | -99.0% | -341.0% | -643.4% | -169.8% |
| EPS (Basic) | $-10.77 | $-6.96 | $-5.07 | $-9.09 | $-0.22 | $-0.69 | $-2.74 | $-0.24 |
| EPS (Diluted) | — | — | — | — | $-0.22 | $-0.69 | $-2.74 | $-0.24 |
| Shares Outstanding (Basic) | 664.8K | 617.9K | 1.7M | 1.3M | 23.4M | 23.4M | 5.4M | 41.9M |
| Shares Outstanding (Diluted) | 664.8K | 617.9K | 1.7M | 1.3M | 23.4M | 23.4M | 5.4M | 41.9M |
| Dividends Per Share | — | — | — | — | — | — | — | — |